Pay in 4 interest-free payments of $6.65 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
The first coprimary endpoint was weight loss of 5% or greater from baseline, which was achieved in 83.3% of the semaglutide group vs
These medications have helped millions of people achieve better health, manage diabetes, and lose weight successfully
Mochi Health: Specific Patient Profiles Who Should Avoid It (and Why) At a glance Service type / GLP-1 telehealth (insurance + cash-pay) Primary medications offered / Semaglutide, tirzepatide, compounded GLP-1 agents Monthly membership fee / Approximately $99/month (as of early 2025) Insurance accepted / Yes, select plans BBB accreditation / Not accredited as of January 2025 FDA-cleared drugs available / Yes (Wegovy, Ozempic, Mounjaro, Zepbound) Key contraindicated profiles / MTC/MEN2 history, active eating disorder, pregnancy, severe renal/hepatic disease LegitScript status / Not certified as of January 2025 Prescriber type / Physician and nurse practitioner-staffed asynchronous + synchronous visits Compounded GLP-1 risk / Compounded semaglutide from 503A/503B pharmacies carries FDA safety warnings What Is Mochi Health and How Does It Work
29 gauge needles 29G represents the beginning of what most practitioners consider the comfortable range for subcutaneous injections
Expect a Certificate of Analysis and temperature logs for transit
While cost, accessibility, and long-term safety considerations persist, current evidence supports its role as a cornerstone
US$ 29.48
US$ 28.24
US$ 25.59
